visitante ::
identificación
|
|||||||||||||||
Buscar | Enviar | Ayuda | Servicio de Bibliotecas | Sobre el DDD | Català English Español |
Página principal > Artículos > Artículos publicados > Prevalence and associations of metabolic syndrome in patients with alcohol use disorder |
Fecha: | 2022 |
Resumen: | Excessive alcohol consumption has been associated with different components of the metabolic syndrome (MetS) such as arterial hypertension, dyslipidemia, type 2 diabetes or obesity. We aimed to analyze the prevalence and associations of MetS in patients with Alcohol Use Disorder (AUD). Cross-sectional study in heavy drinkers admitted for the treatment of AUD between 2013 and 2017. Medical comorbidity, anthropometric data, alcohol use and biological parameters were obtained. MetS was established according to the harmonized definition. A total of 728 patients (22% women) were included; median age was 47 years (IQR: 40-53. 5), median alcohol consumption was 160 g/day (IQR: 115-240) and prevalence of MetS was 13. 9%. The multivariate analysis showed a significant dose-response effect of estimated glomerular filtration (eGFR) and MetS: relative to patients with eGFR > 90 mL/min, those with eGFR (60-90 mL/min) and those with eGFR < 60 mL/min were 1. 93 times (95% CI 1. 18-3. 15) and 5. 61 times (95% CI 1. 66-19. 0) more likely to have MetS, respectively. MetS was significantly associated with hyperuricemia (OR 2. 28, 95% CI 1. 36-3. 82) and elevated serum GGT (OR 3. 67, 95% CI 1. 80-7. 46). Furthermore, for every increase of 1 year in age, the probability of MetS increased significantly (OR 1. 03, 95% CI 1. 01-1. 05). MetS in heavy drinkers is independently associated with reduced kidney function and metabolic risk factors including hyperuricemia and elevated serum GGT. |
Ayudas: | Instituto de Salud Carlos III RD16/0017/0003 Instituto de Salud Carlos III PI17/00174 Instituto de Salud Carlos III PI20/00883 Instituto de Salud Carlos III RD21/0009/0004 Ministerio de Sanidad, Servicios Sociales e Igualdad 2018/020 Ministerio de Sanidad, Servicios Sociales e Igualdad 2020/024 Agència de Gestió d'Ajuts Universitaris i de Recerca 2017SGR316 |
Derechos: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
Lengua: | Anglès |
Documento: | Article ; recerca ; Versió publicada |
Materia: | Endocrine system and metabolic diseases ; Metabolic disorders ; Addiction |
Publicado en: | Scientific reports, Vol. 12 (february 2022) , ISSN 2045-2322 |
7 p, 1.1 MB |